###begin article-title 0
Polymorphisms within Novel Risk Loci for Type 2 Diabetes Determine beta-Cell Function
###end article-title 0
###begin p 1
Conceived and designed the experiments: NS AF. Performed the experiments: FM OT CT KK SS KK. Analyzed the data: HS FM NS AF. Wrote the paper: HS. Other: Designed the experiments/the study: HH. Contributed to the writing of the paper: HH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 355 362 352 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 364 368 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 370 374 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 380 389 377 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387761</italic>
Type 2 diabetes arises when insulin resistance-induced compensatory insulin secretion exhausts. Insulin resistance and/or beta-cell dysfunction result from the interaction of environmental factors (high-caloric diet and reduced physical activity) with a predisposing polygenic background. Very recently, genetic variations within four novel genetic loci (SLC30A8, HHEX, EXT2, and LOC387761) were reported to be more frequent in subjects with type 2 diabetes than in healthy controls. However, associations of these variations with insulin resistance and/or beta-cell dysfunction were not assessed.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 170 177 170 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 201 205 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 428 432 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 437 446 437 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387761</italic>
By genotyping of 921 metabolically characterized German subjects for the reported candidate single nucleotide polymorphisms (SNPs), we show that the major alleles of the SLC30A8 SNP rs13266634 and the HHEX SNP rs7923837 associate with reduced insulin secretion stimulated by orally or intravenously administered glucose, but not with insulin resistance. In contrast, the other reported type 2 diabetes candidate SNPs within the EXT2 and LOC387761 loci did not associate with insulin resistance or beta-cell dysfunction, respectively.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 13 20 13 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
The HHEX and SLC30A8 genes encode for proteins that were shown to be required for organogenesis of the ventral pancreas and for insulin maturation/storage, respectively. Therefore, the major alleles of type 2 diabetes candidate SNPs within these genetic loci represent crucial alleles for beta-cell dysfunction and, thus, might confer increased susceptibility of beta-cells towards adverse environmental factors.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 463 466 463 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Freeman1">[1]</xref>
###xml 969 972 963 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Weyer1">[2]</xref>
###xml 1130 1135 1121 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 1135 1138 1126 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Koch1">[3]</xref>
###xml 1139 1142 1130 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Hara1">[5]</xref>
###xml 1206 1212 1197 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 1212 1215 1203 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Barroso1">[6]</xref>
###xml 1216 1219 1207 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Nielsen1">[8]</xref>
###xml 1221 1227 1212 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 1227 1230 1218 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Steinthorsdottir1">[9]</xref>
###xml 1236 1242 1227 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1242 1246 1233 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Grant1">[10]</xref>
###xml 1247 1251 1238 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Florez1">[13]</xref>
Type 2 diabetes mellitus (T2DM) reaches epidemic dimensions in western industrialized nations and is caused by environmental factors, such as high-caloric fat- and carbohydrate-enriched diets and a sedentary lifestyle with markedly reduced physical activity. Moreover, as one of the most recognized polygenic diseases, T2DM is due to variations within several genetic loci that confer increased susceptibility towards the above mentioned environmental challenges [1]. Linkage studies, candidate-gene approaches, and genome-wide association studies identified single nucleotide polymorphisms (SNPs) within currently up to ten genes which associate with an increased T2DM risk. During the pathogenesis of T2DM, insulin resistance of peripheral tissues (liver, skeletal muscle, and adipose tissue) provokes compensatory increments in insulin secretion by pancreatic beta-cells. When insulin resistance is no longer compensated and beta-cells exhaust, hyperglycemia arises [2]. Thus, most T2DM risk loci are supposed to contribute to beta-cell dysfunction. In fact, among the most prominent T2DM risk loci up to now, only SNPs within PPARG[3]-[5] contribute to altered insulin sensitivity, whereas SNPs within KCNJ11[6]-[8], CDKAL1[9], and TCF7L2[10]-[13] impair beta-cell function.
###end p 9
###begin p 10
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Sladek1">[14]</xref>
###xml 166 173 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 191 200 191 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387761</italic>
###xml 444 451 444 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 453 457 453 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 459 463 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 469 478 469 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387761</italic>
In the first very recently reported genome-wide association study for T2DM [14], four novel T2DM risk loci were identified. The role of the corresponding genes, i.e. SLC30A8, HHEX, EXT2, and LOC387761, in the development of prediabetes phenotypes was not assessed and is not established in the literature. Therefore, it was the aim of the present study to test the association of the recently identified candidate SNPs within or near the genes SLC30A8, HHEX, EXT2, and LOC387761 with insulin resistance and beta-cell dysfunction in a thoroughly metabolically characterized German population at an increased risk for T2DM.
###end p 10
###begin title 11
Methods
###end title 11
###begin title 12
Subjects
###end title 12
###begin p 13
###xml 643 645 631 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 677 689 <span type="species:ncbi:9606">participants</span>
###xml 1151 1163 <span type="species:ncbi:9606">participants</span>
###xml 1255 1267 <span type="species:ncbi:9606">participants</span>
One thousand non-diabetic subjects were recruited from the southern part of Germany and participated in the ongoing Tubingen Family Study for T2DM (TUF) which currently includes approximately2000 individuals. Recruitment of the subjects was based on (i) exclusion of subjects with anti-glutamic acid decarboxylase antibodies, impaired glucose tolerance, and T2DM as well as (ii) inclusion of subjects of whom DNA samples and C-peptide measurements were available. From the 1000 subjects selected in this way, 79 subjects were excluded due to incomplete data sets. 71 % of the subjects had a recorded family history of T2DM, i.e. at least one 2nd-degree relative with T2DM. All participants underwent the standard procedures of the protocol including medical history and physical examination, assessment of smoking status, alcohol consumption habits and activity, routine blood tests, and oral glucose tolerance test (OGTT). A subgroup of 491 subjects voluntarily agreed to undergo a hyperinsulinemic-euglycemic clamp. Another subgroup of the clamped subjects (N = 150) additionally agreed to undergo an intravenous glucose tolerance test (IVGTT). The participants were not taking any medication known to affect glucose tolerance or insulin secretion. The participants gave informed written consent to the study, and the protocol was approved by the local ethical committee (Ethik-Kommission der Medizinischen Fakultat der Universitat Tubingen).
###end p 13
###begin title 14
Genotyping of the study population
###end title 14
###begin p 15
For genotyping, DNA was isolated from whole blood using a commercial DNA isolation kit (NucleoSpin, Macherey & Nagel, Duren, Germany). SNPs were genotyped using the TaqMan assay (Applied Biosystems, Foster City, CA, USA). The TaqMan genotyping reaction was amplified on a GeneAmp PCR system 7000 (50degreesC for 2 min, 95degreesC for 10 min, followed by 40 cycles of 95degreesC for 15 s and 60degreesC for 1 min), and fluorescence was detected on an ABI Prism sequence detector (Applied Biosystems, Foster City, CA, USA).
###end p 15
###begin title 16
Body composition and body fat distribution
###end title 16
###begin p 17
###xml 172 173 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Body composition was measured by bioelectrical impedance as the percentage of body fat. Body mass index (BMI) was calculated as weight divided by the square of height (kg/m2). Waist circumference was measured in the upright position at the midpoint between the lateral iliac crest and the lowest rib.
###end p 17
###begin title 18
OGTT
###end title 18
###begin p 19
After a 10-h overnight fast, all subjects underwent a 75-g OGTT and venous blood samples were obtained at 0, 30, 60, 90, and 120 min for determination of plasma glucose, insulin, and C-peptide.
###end p 19
###begin title 20
Hyperinsulinemic-euglycemic clamp and IVGTT
###end title 20
###begin p 21
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Tripathy1">[15]</xref>
###xml 154 159 <span type="species:ncbi:9606">human</span>
After an overnight fast and a 60-min. baseline period, 491 subjects received a priming dose of insulin followed by an infusion (40 mU/m2) of short-acting human insulin for 120 min. A variable infusion of 20 % (w/v) glucose was started to maintain the plasma glucose concentration at 5.5 mM. Blood samples for the measurement of plasma glucose were obtained at 5-min. intervals throughout the clamp. Plasma insulin levels were measured at baseline and in the steady state of the clamp. In a subgroup of the clamped subjects (N = 150), an IVGTT was performed prior to the clamp, as described by the Botnia protocol [15]. After baseline samples had been collected, a 0.3 g/kg body weight glucose dose of a 20 % (w/v) glucose solution was given at time 0. Blood samples for the measurement of plasma glucose, insulin, and C-peptide were obtained at 2, 4, 6, 8, 10, 20, 30, 40, 50, and 60 min.
###end p 21
###begin title 22
Determination of blood parameters
###end title 22
###begin p 23
Plasma glucose was determined using a bedside glucose analyzer (glucose oxidase method, Yellow Springs Instruments, Yellow Springs, CO, USA). Plasma insulin levels were determined by microparticle enzyme immunoassay (Abbott Laboratories, Tokyo, Japan), and plasma C-peptide by radioimmunoassay (Byk-Sangtec, Dietzenbach, Germany).
###end p 23
###begin title 24
Calculations
###end title 24
###begin p 25
###xml 98 99 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 103 105 103 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30</sub>
###xml 109 111 109 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">60</sub>
###xml 115 117 115 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
###xml 125 128 125 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">120</sub>
###xml 500 504 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Stumvoll1">[16]</xref>
###xml 614 615 614 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 619 620 619 620 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 730 734 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Matsuda1">[17]</xref>
###xml 747 748 747 748 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 752 753 752 753 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 757 761 757 761 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mean</sub>
###xml 765 769 765 769 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mean</sub>
###xml 770 775 770 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#189;</sup>
###xml 975 977 967 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 981 983 973 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
The area under the curve (AUC) of plasma glucose levels during OGTT was calculated as 0.5.(0.5.Glc0+Glc30+Glc60+Glc90+0.5.Glc120). The AUC of plasma C-peptide levels during OGTT was calculated analogously. Insulin secretion in the OGTT was assessed by calculating the AUC of C-peptide divided through the AUC of glucose (AUC C-pep/AUC glc). First-phase insulin secretion (in nM) was estimated from plasma insulin and glucose concentrations during OGTT using validated equations as described formerly [16]. Homeostasis model assessment of insulin resistance (HOMA-IR, in arbitrary units, U) was calculated as (2.Glc0.Ins0)/45. Insulin sensitivity from OGTT (in arbitrary units, U) was estimated as proposed by Matsuda and DeFronzo [17]: 10,000/(Glc0.Ins0.Glcmean.Insmean)(1/2). Clamp-derived insulin sensitivity (in arbitrary units, U) was calculated as glucose infusion rate necessary to maintain euglycemia during the last 40 min. (steady state) of the clamp (in micromol.kg-1.min-1) divided by the steady-state insulin concentration.
###end p 25
###begin title 26
Statistical analyses
###end title 26
###begin p 27
###xml 106 107 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Unless otherwise stated, the data are given as means+/-SE. Hardy-Weinberg equilibrium was tested using chi2 test. Simple and multivariate linear regression analyses were carried out after log-transformation of data followed by ANOVA. In multivariate linear regression models, the trait (index of insulin sensitivity/secretion) was chosen as dependent variable. Two-group comparisons were performed using Student's t-test. Differences between time courses were tested by MANOVA for repeated measures. A p-value<0.05 was considered statistically significant. In our cohort of 921 subjects, we were able to detect an effect size (delta) of 1/5 standard deviation (sigma) of a quantitative trait with a power of 100 % in the additive as well as the dominant model. Effect sizes of 1/10 sigma were still detected with 78 % power in the additive model and with 86 % power in the dominant model. The statistical software package JMP 4.0 (SAS Institue, Cary, NC, USA) was used.
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 74 81 74 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000832-t001">Table 1</xref>
###xml 155 159 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 342 349 342 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 438 447 438 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387761</italic>
###xml 513 517 513 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 746 747 746 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 801 805 801 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 941 945 941 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 1010 1011 1010 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1259 1263 1259 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Sladek1">[14]</xref>
###xml 1265 1273 1265 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000832-t002">Tables 2</xref>
###xml 1278 1279 1278 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000832-t003">3</xref>
We genotyped 921 non-diabetic subjects (clinical characteristics given in Table 1) for the three intronic SNPs rs3740878, rs11037909, and rs1113132 of the EXT2 gene (chr. 11), for the two SNPs rs1111875 and rs7923837 in the 3'-flanking region of the HHEX gene (chr. 10), for the non-synonymous SNP rs13266634 (R325W) in the final exon of the SLC30A8 gene (chr. 8), and for SNP rs7480010 in the 5'-flanking region of the hypothetical gene LOC387761 (chr. 11). During genotyping of the first 80 subjects, the three EXT2 SNPs revealed complete genetic linkage consistent with recent phase II data of the International HapMap Project derived from Utah residents with ancestry from northern and western Europe (release #21a January 2007, , D' = 1.0, r2 = 1.0 for all three SNP pairs). Therefore, among the EXT2 SNPs, rs11037909 was arbitrarily chosen as representative and further analysed. According to HapMap data, both SNPs located within the HHEX locus were not in complete linkage disequilibrium (D' = 0.959, r2 = 0.698) and therefore analysed separately in the total study population. The five remaining completely analysed SNPs were in Hardy-Weinberg equilibrium (p>0.4, all) and displayed minor allele frequencies (MAFs) similar to those recently reported [14] (Tables 2 and 3). The overall genotyping success rate was 99.98 %, and rescreening of 3.16 % of subjects gave 100 % identical results.
###end p 29
###begin title 30
Clinical characteristics of the study population (N = 921).
###end title 30
###begin p 31
###xml 16 24 16 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000832-t002">Tables 2</xref>
###xml 29 30 29 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000832-t003">3</xref>
###xml 176 183 176 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 394 401 394 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000832-t002">Table 2</xref>
###xml 700 707 700 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000832-t002">Table 2</xref>
###xml 854 862 854 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000832-t002">Tables 2</xref>
###xml 867 868 867 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000832-t003">3</xref>
###xml 958 962 958 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 979 986 979 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 1007 1016 1007 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387761</italic>
###xml 1046 1053 1046 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000832-t002">Table 2</xref>
###xml 1091 1095 1091 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 1364 1371 1364 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000832-t003">Table 3</xref>
As presented in Tables 2 and 3, none of the SNPs significantly correlated with anthropometric data, such as gender, age, BMI, or body fat content. Only the minor allele of the SLC30A8 SNP rs13266634 significantly correlated with elevated waist circumference (p = 0.0366) and showed a trend towards a correlation with higher BMI (P = 0.0507) pointing to an association with abdominal adiposity (Table 2). Moreover, the minor allele of the same SNP displayed a significant correlation with lower insulin sensitivity, as measured by the hyperinsulinemic-euglycemic clamp (p = 0.0077) which however disappeared after adjustment for gender, age, and BMI (significant determinants of insulin sensitivity) (Table 2). None of the other SNPs was significantly associated with indices of insulin sensitivity derived from OGTT or hyperinsulinemic-euglycemic clamp (Tables 2 and 3). With different OGTT-derived measures of insulin secretion, no reliable associations of EXT2 SNP rs11037909, SLC30A8 SNP rs13266634, and LOC387761 SNP rs7480010 were detected (Table 2). However, the major alleles of both HHEX SNPs were significantly correlated with reduced insulin secretion, as estimated from all three OGTT-derived indices of insulin secretion, even after adjustment for gender, age, BMI, and OGTT-derived insulin sensitivity (significant determinants of insulin secretion) (Table 3). Adjustment for fasting plasma glucose, instead of OGTT-derived insulin sensitivity, resulted in very similar results (data not shown).
###end p 31
###begin title 32
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 65 74 65 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387761</italic>
Correlations of EXT2 SNP rs11037909, SLC30A8 SNP rs13266634, and LOC387761 SNP rs7480010 with insulin sensitivity and insulin secretion.
###end title 32
###begin p 33
###xml 232 233 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 247 248 247 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 276 277 276 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
For statistical analysis, data were log-transformed. Plasma glucose levels and indices of insulin sensitivity were adjusted for gender, age, and BMI. Indices of insulin secretion were adjusted for gender, age, BMI, and ISI (OGTT). p1-unadjusted; p2-adjusted, additive model; p3 - adjusted, dominant model. AUC - area under the curve; HOMA-IR - homeostasis model assessment of insulin resistance; ISI - insulin sensitivity index; MAF - minor allele frequency; SNP - single nucleotide polymorphism. *subgroup (N = 491).
###end p 33
###begin title 34
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
Correlations of HHEX SNPs rs1111875 and rs7923837 with insulin sensitivity and insulin secretion.
###end title 34
###begin p 35
###xml 232 233 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 249 250 249 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 280 281 280 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
For statistical analysis, data were log-transformed. Plasma glucose levels and indices of insulin sensitivity were adjusted for gender, age, and BMI. Indices of insulin secretion were adjusted for gender, age, BMI, and ISI (OGTT). p1 - unadjusted; p2 - adjusted, additive model; p3 - adjusted, dominant model. AUC - area under the curve; HOMA-IR - homeostasis model assessment of insulin resistance; ISI - insulin sensitivity index; MAF - minor allele frequency; SNP - single nucleotide polymorphism. *subgroup (N = 491).
###end p 35
###begin p 36
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 234 243 234 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387761</italic>
###xml 533 541 533 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000832-g001">Figure 1</xref>
###xml 564 571 564 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 595 599 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 836 843 836 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 867 871 867 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 1002 1006 1002 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 1223 1227 1223 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 1372 1379 1372 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000832-t003">Table 3</xref>
To assess the effects of the candidate SNPs specifically on glucose-stimulated insulin secretion, we analysed data obtained from an IVGTT in a subgroup of 150 subjects. The incremental AUC of insulin levels of EXT2 SNP rs11037909 and LOC387761 SNP rs7480010 were not significantly correlated with insulin secretion prior to (p = 0.9 and p = 0.8, respectively, dominant model) as well as after adjustment for gender, age, BMI, and clamp-derived insulin sensitivity (p = 0.8 and p = 0.6, respectively, dominant model). As presented in Figure 1, the major alleles of SLC30A8 SNP rs13266634 and the HHEX SNP rs7923837 were significantly correlated with reduced insulin secretion prior to adjustment (p = 0.0029 and p = 0.0359, respectively, dominant model). After adjustment for gender, age, BMI, and clamp-derived insulin sensitivity, the SLC30A8 SNP rs13266634 and the HHEX SNP rs7923837 remained significantly correlated with insulin secretion (p = 0.0416 and p = 0.0254, respectively, dominant model). HHEX SNP rs1111875 showed a trend towards an association with insulin secretion that however did not withstand adjustment (unadjusted p = 0.09, adjusted p = 0.16, dominant model). The pathophysiological importance of the HHEX SNP rs7923837 was further stressed by the significant correlation of its major allele with increased plasma glucose levels at 120 min. of OGTT (Table 3).
###end p 36
###begin title 37
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
Association of SLC30A8 SNP rs13266634 (A) and HHEX SNPs rs1111875 (B) and rs7923837 (C) with glucose-stimulated insulin secretion.
###end title 37
###begin p 38
Plasma levels of glucose (lower panels) and insulin (upper panels) during IVGTT. Dominant model: black circles - homozygous carriers of the major allele; white circles: heterozygous and homozygous carriers of the minor allele.
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Sladek1">[14]</xref>
###xml 193 200 193 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 423 427 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 451 460 451 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387761</italic>
###xml 564 568 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 573 582 573 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387761</italic>
###xml 680 683 680 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Steinthorsdottir1">[9]</xref>
###xml 685 689 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Saxena1">[18]</xref>
###xml 690 694 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Scott1">[20]</xref>
In summary, we did not detect associations of the recently reported T2DM candidate SNPs [14] with state-of-the-art measures of insulin sensitivity. The significant correlation observed between SLC30A8 SNP rs13266634 and clamp-derived insulin sensitivity was not retained after adjustment for gender, age, and BMI, and thus might be due to this SNP's effect on (abdominal) adiposity. Furthermore, neither the representative EXT2 SNP rs11037909 nor the LOC387761 SNP rs7480010 were associated with insulin secretion, as assessed by OGTT and IVGTT. Moreover, neither EXT2 nor LOC387761 could be confirmed as T2DM genes in four very recently published genome-wide association studies [9], [18]-[20]. Thus, further studies that should include the analysis of the complete genetic variation within these loci are needed to finally clarify these genes' roles in the pathogenesis of T2DM.
###end p 40
###begin p 41
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 585 589 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 777 781 777 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 797 800 797 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Steinthorsdottir1">[9]</xref>
###xml 802 806 802 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Saxena1">[18]</xref>
###xml 807 811 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Scott1">[20]</xref>
###xml 853 857 853 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Sladek1">[14]</xref>
###xml 859 863 859 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 989 993 989 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Bort1">[21]</xref>
###xml 995 999 995 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Bort2">[22]</xref>
In contrast, we observed clear associations of SNP rs7923837 within the HHEX locus with insulin secretion indices derived from OGTT as well as with glucose-stimulated insulin secretion during the IVGTT. Even though our statistical data were not corrected for multiple comparisons, this SNP's association with measures of insulin secretion derived from two independent methods (OGTT and IVGTT) largely excludes the possibility of a by-chance finding. Moreover, the association of SNP rs7923837 with plasma glucose levels at 120 min. of OGTT indeed suggests a very important role of the HHEX gene in the development of impaired glucose tolerance and T2DM. This is further strengthened by the aformentioned genome-wide association studies all of which confirmed the importance of HHEX as a T2DM gene [9], [18]-[20]. As already pointed out by Sladek et al. [14], HHEX's role in the predispostion to T2DM could be attributed to this gene's function during organogenesis of the ventral pancreas [21], [22].
###end p 41
###begin p 42
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 390 394 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Chimienti1">[23]</xref>
###xml 396 400 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Chimienti2">[24]</xref>
###xml 486 493 480 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 602 606 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Saxena1">[18]</xref>
###xml 607 611 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000832-Scott1">[20]</xref>
At the moment, we cannot explain the discrepancy between the association of SLC30A8 SNP rs13266634 with glucose-stimulated insulin secretion during the IVGTT and the lack of association with OGTT-derived parameters for insulin secretion. However, this gene's function as a zinc transporter in secretory vesicles of pancreatic beta-cells providing zinc for insulin maturation and/or storage [23], [24] renders this gene a very plausible candidate for beta-cell dysfunction. In addition, SLC30A8 was replicated as a T2DM gene in three out of four of the recently reported genome-wide association studies [18]-[20].
###end p 42
###begin p 43
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
In conclusion, genetic variants of the HHEX and SLC30A8 loci are associated with altered glucose-stimulated insulin secretion. Therefore, the major alleles of candidate SNPs within these loci represent crucial alleles for beta-cell dysfunction and, thus, might confer increased susceptibility of beta-cells towards adverse environmental factors.
###end p 43
###begin p 44
###xml 19 31 <span type="species:ncbi:9606">participants</span>
We thank all study participants for their cooperation. We thank the International HapMap Consortium for the public allocation of genotype data. We gratefully acknowledge the excellent technical assistance of Anna Bury, Alke Guirguis, Heike Lutz, Melanie Weisser, and Roman Werner.
###end p 44
###begin title 45
References
###end title 45
###begin article-title 46
Type-2 diabetes: a cocktail of genetic discovery.
###end article-title 46
###begin article-title 47
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
###end article-title 47
###begin article-title 48
###xml 96 104 <span type="species:ncbi:9606">patients</span>
The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects.
###end article-title 48
###begin article-title 49
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.
###end article-title 49
###begin article-title 50
The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.
###end article-title 50
###begin article-title 51
Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action.
###end article-title 51
###begin article-title 52
Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.
###end article-title 52
###begin article-title 53
The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes.
###end article-title 53
###begin article-title 54
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.
###end article-title 54
###begin article-title 55
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.
###end article-title 55
###begin article-title 56
###xml 112 117 <span type="species:ncbi:9606">women</span>
###xml 122 125 <span type="species:ncbi:9606">men</span>
Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men.
###end article-title 56
###begin article-title 57
Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk.
###end article-title 57
###begin article-title 58
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
###end article-title 58
###begin article-title 59
A genome-wide association study identifies novel risk loci for type 2 diabetes.
###end article-title 59
###begin article-title 60
Importance of obtaining independent measures of insulin secretion and insulin sensitivity during the same test: results with the Botnia clamp.
###end article-title 60
###begin article-title 61
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.
###end article-title 61
###begin article-title 62
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.
###end article-title 62
###begin article-title 63
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
###end article-title 63
###begin article-title 64
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.
###end article-title 64
###begin article-title 65
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.
###end article-title 65
###begin article-title 66
Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas.
###end article-title 66
###begin article-title 67
Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development.
###end article-title 67
###begin article-title 68
Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules.
###end article-title 68
###begin article-title 69
In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion.
###end article-title 69
###begin p 70
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 70
###begin p 71
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The study was supported by a grant from the German Research Foundation (KFO 114/2).
###end p 71

